(S)-2-Amino-2-(3-fluorophenyl)ethanol, 95.0%, 10g

2-methyl-1-(4-methylphenyl)-3-(piperidin-1-yl)propan-1-one hydrochloride, 95.0%, 5g

N-(2,4-Dimethoxybenzyl)-1,3,4-thiadiazol-2-amine, 95%, 5g

Methyl 3-(2-hydroxyethyl)benzoate, 98%, 250mg

Perchloric acid, ROTIPURAN® 70%, pa, 1 l, glass packaging

(9H-fluoren-9-yl)methyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate, 98%, 500mg

o-Dianisidine [for Biochemical Research]>90.0%(T)5g

1,5-Naphthyridin-2(1H)-one, 95.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 2, 10 µl, 1701 RN, 1 piece

Copper(II) nitrate hydrate, ROTI®METIC 99.999% (5N), 5 g, HDPE

Formic acid 85 % 20 Liter

1-(2-ethoxyethyl)-2-methylpiperazine, 95.0%, 1g

3-Chloro-5-methylthio-1,2,4-thiadiazole, 500mg